Loading...

MGTX MEIRAGTX HOLDINGS PLC US FDA Inspections 8-K Filing

MRGT

MGTX

MEIRAGTX HOLDINGS PLC

(MGTX)

2025 8-K

Financial Agreement Update

Share Repurchase Agreement

Financial Results Report

Collaboration Agreement

Financial Results Released

Financial Statements

Pre-Market Approval

Lease Agreement

Strategic Collaboration

FDA Designation Granted

Financial Results

Positive Study Results

Financial Results

Annual General Meeting

Financial Results Announcement

Amendment to Board Appointm...

Financial Results Announcement

Asset Purchase Agreement

Financial Results Announcement

Investment Agreement with S...

Agreement with Perceptive C...

Annual General Meeting

Financial Results Announcement

Private Placement

Resignation of Director

Financial Results Announcement

External Links:

On May 9, 2025, MeiraGTx Holdings plc announced that the U.S. FDA granted its therapy AAV-GAD for Parkinson’s disease the Regenerative Medicine Advanced Therapy designation.

AI Assistant

MEIRAGTX HOLDINGS PLC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.